0.4787
Schlusskurs vom Vortag:
$0.479
Offen:
$0.471
24-Stunden-Volumen:
370.10K
Relative Volume:
0.03
Marktkapitalisierung:
$21.17M
Einnahmen:
$106.79M
Nettoeinkommen (Verlust:
$-8.73M
KGV:
-2.3935
EPS:
-0.2
Netto-Cashflow:
$10.81M
1W Leistung:
-0.79%
1M Leistung:
+7.65%
6M Leistung:
-63.46%
1J Leistung:
-83.77%
Harvard Bioscience Inc Stock (HBIO) Company Profile
Firmenname
Harvard Bioscience Inc
Sektor
Telefon
(508) 893-8999
Adresse
84 OCTOBER HILL RD, HOLLISTON, MA
Vergleichen Sie HBIO mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
HBIO
Harvard Bioscience Inc
|
0.4787 | 23.34M | 106.79M | -8.73M | 10.81M | -0.20 |
![]()
ISRG
Intuitive Surgical Inc
|
477.78 | 168.51B | 9.15B | 2.61B | 1.99B | 7.17 |
![]()
BDX
Becton Dickinson Co
|
193.13 | 55.46B | 21.39B | 1.59B | 2.55B | 5.56 |
![]()
ALC
Alcon Inc
|
85.08 | 42.41B | 9.93B | 1.12B | 1.58B | 2.25 |
![]()
RMD
Resmed Inc
|
281.71 | 41.63B | 5.15B | 1.40B | 1.65B | 9.51 |
![]()
WST
West Pharmaceutical Services Inc
|
238.74 | 17.33B | 2.90B | 467.20M | 306.90M | 6.37 |
Harvard Bioscience Inc Stock (HBIO) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-04-09 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
2023-03-10 | Hochstufung | The Benchmark Company | Speculative Buy → Buy |
2021-01-07 | Hochstufung | The Benchmark Company | Speculative Buy → Buy |
2020-12-09 | Eingeleitet | Northland Capital | Outperform |
2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
2019-07-08 | Herabstufung | Janney | Buy → Neutral |
2018-01-24 | Bestätigt | Janney | Buy |
2018-01-23 | Bestätigt | The Benchmark Company | Buy |
2016-11-17 | Eingeleitet | Singular Research | Buy |
2015-07-28 | Eingeleitet | The Benchmark Company | Buy |
Alle ansehen
Harvard Bioscience Inc Aktie (HBIO) Neueste Nachrichten
Harvard Bioscience 2025 Q2 Earnings Narrows Losses with 22% Drop in Net Loss - AInvest
Harvard Bioscience: Q2 Earnings Snapshot - Norwalk Hour
Harvard Bioscience Inc (HBIO) Q2 2025 Earnings Call Highlights: Navigating Revenue Challenges ... By GuruFocus - Investing.com Canada
Harvard Bioscience Reports Q2 2025 Financial Results - TipRanks
Harvard Bioscience Q2 2025: Unpacking Contradictions in NIH Funding, Refinance Terms, and China Market Outlook - AInvest
Harvard Bioscience Amends Credit Agreement with Lenders - TipRanks
Harvard Bioscience Delivers Steady Results And Eyes Growth Ahead - Finimize
Harvard Bioscience Delivers Steady Results And Improved Cash Flow - Finimize
Harvard Bioscience outlines $19M–$21M Q3 revenue target as debt refinancing advances and product adoption accelerates - MSN
Harvard Bioscience Q2 2025 Earnings Call Transcript - MarketBeat
Harvard Bioscience: Navigating Debt and Innovation in the Biotech Tools Sector - AInvest
Harvard Bioscience earnings missed, revenue fell short of estimates By Investing.com - Investing.com Canada
Earnings call transcript: Harvard Bioscience Q2 2025 results show mixed signals - Investing.com Nigeria
Transcript : Harvard Bioscience, Inc., Q2 2025 Earnings Call, Aug 11, 2025 - MarketScreener
Harvard Bioscience Q2 2025 slides: improved profitability despite revenue challenges - Investing.com Canada
Harvard Bioscience's Q2 2025 Performance: A Strategic Turnaround Amid Debt Refinancing Challenges - AInvest
Harvard Bioscience Reports Q2 Earnings Beat, Initiates Q3 Outlook - AInvest
Harvard Bioscience Tops Q2 Revenue Views - The Motley Fool
Harvard Bioscience Q2 revenue meet estimates - MarketScreener
Harvard Bioscience Q2 2025 Financial Results - TradingView
Harvard Bioscience Announces Second Quarter 2025 Financial Results - GlobeNewswire
Harvard Bioscience Q2 Earnings: Revenue Beats Guidance as New CEO Charts Turnaround Path - Stock Titan
Will Harvard Bioscience Inc. benefit from macro trendsFree High Conviction Intraday Stock Signals - Newser
Harvard Bioscience Inc. stock daily chart insights2-Day Signal Watch with Forecast Outcome - Newser
Harvard Bioscience Inc. stock outlook for YEARStock Entry Points Based on Technicals - Newser
Why Harvard Bioscience Inc. stock attracts strong analyst attentionFree Real Time Alerts Based on AI Prediction - Newser
Relative strength of Harvard Bioscience Inc. in sector analysisFree Alert Feed for Momentum Based Picks - Newser
What earnings revisions data tells us about Harvard Bioscience Inc.Free Weekly Potential Breakout Stock List - Newser
Is Harvard Bioscience Inc. stock poised for growthReal Chart Based Opportunity Identification - Newser
Real time scanner hits for Harvard Bioscience Inc. explainedFree Proven Entry Plan With Low Risk Trade - Newser
Harvard Bioscience HBIO 2025Q2 Earnings Preview Upside Anticipated on Innovative Gene Therapy Developments - AInvest
Harvard Bioscience Inc expected to post a loss of 1 cent a shareEarnings Preview - TradingView
Earnings To Watch: Harvard Bioscience Inc (HBIO) Reports Q2 2025 Result - Yahoo Finance
Chart overlay techniques for tracking Harvard Bioscience Inc.AI Intraday Market Movement Prediction Tool - Newser
Harvard Bioscience Enters Sixth Amendment To Credit Agreement; Lenders Agree Not To Test Financial Covenants For Q3 2025; Agrees To Pay $400K Fees To Lenders; Explores Alternative Capital Sources For Refinancing; Says There Is Substantial Doubt - 富途牛牛
Harvard Bioscience announces CEO succession plan - MSN
Harvard Bioscience Sets Q2 2025 Earnings Release and Conference Call - AInvest
Harvard Bioscience, Inc. to Release Q2 2025 Financial Results and Host Conference Call on August 11, 2025 - Quiver Quantitative
Harvard Bioscience Schedules Second Quarter 2025 Earnings Conference Call for August 11, 2025 at 8:00 AM ET - GlobeNewswire
Harvard Bioscience Upcoming Q2 2025 Earnings: Pre-Market Release and Conference Call Details Revealed - Stock Titan
Published on: 2025-08-04 19:22:29 - beatles.ru
Using R and stats models for Harvard Bioscience Inc. forecastingFree Capital Growth With Controlled Risk Picks - Newser
Harvard Bioscience Inc. Stock Analysis and ForecastInvest confidently with professional market insights - Jammu Links News
What are analysts’ price targets for Harvard Bioscience Inc. in the next 12 monthsFree Trading Psychology Coaching - Jammu Links News
What makes Harvard Bioscience Inc. stock price move sharplyPhenomenal trading returns - Jammu Links News
Is Harvard Bioscience Inc. stock overvalued or undervaluedUnlock exclusive trading tools and resources - Jammu Links News
What drives Harvard Bioscience Inc. stock priceBuild a portfolio for long-term financial success - Jammu Links News
How volatile is Harvard Bioscience Inc. stock compared to the marketUnlock your portfolio’s hidden potential - Jammu Links News
What is Harvard Bioscience Inc. company’s growth strategyPowerful market insights - Jammu Links News
Is Harvard Bioscience Inc. a growth stock or a value stockFree Capital Allocation Plans - Jammu Links News
How does Harvard Bioscience Inc. compare to its industry peersBuild a diversified portfolio for risk mitigation - Jammu Links News
Finanzdaten der Harvard Bioscience Inc-Aktie (HBIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):